Vimarsana
Biggest News Aggregation in the World

Page 3 - Turing Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Turing Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Turing Pharmaceutical Today - Breaking & Trending Today

Big Pharma's new popularity may end prescription drug reform - The San Diego Union-Tribune - Vimarsana News

Big Pharma's new popularity may end prescription drug reform - The San Diego Union-Tribune

The very successful rollout of three COVID-19 vaccines has changed public opinion. Possible breakthroughs on cancer and HIV may provide another boost.

Why People Don't Trust Pfizer's Covid Vaccine - Vimarsana News

Why People Don't Trust Pfizer's Covid Vaccine

Michael Shermer, a famous skeptic, was forced to admit that one of the reasons is that  some of them are true. In his research he found that the fact that some conspiracy theories are real feeds people’s suspicion and makes them susceptible to the belief in others that are far less credible. We are increasingly herded into taking a hard line on issues which are nuanced. One example of this is an apparent increase in two camps: some people are entirely against mainstream medicine while others will bend over backwards to mount an extreme defense of the indefensible excesses of Big Pharma.

Detailed text transcripts for TV channel - MSNBC - 20150923:09:42:00 - Vimarsana News

Detailed text transcripts for TV channel - MSNBC - 20150923:09:42:00

Despite bitter objections and no votes from the czech republic hungary, romania and slovakia. the plan only addresses a tiny fraction of the migrants flowing in to europe. some 35,000 entered croatia in just six days last week. the drug company that's been taking heat for a 5,000% overnight increase on a critical prescription drug is now rolling that hike back. the medication is called daraprim, and is used to treat people with weakened immune systems from pregnant women to people with aids. the ceo of turing pharmaceutical, a 32-year-old former hedge fund manager, initially justified the pr...

Detailed text transcripts for TV channel - MSNBC - 20150923:09:10:00 - Vimarsana News

Detailed text transcripts for TV channel - MSNBC - 20150923:09:10:00

Turing pharmaceutical ceo seems to be rethinking his stance on a drug used to treat a life threatening parasitic infection. on monday you may recall he gave a resounding no when cnbc's meg terrell asked if he would roll back the 5,000% price hike of daraprim. he initially said the increase would go to researching a new pill. but, some medical experts, they are reskeptical. >> we don't need another drug in this space. and there's no indication that this guy has any idea how to do drug research and development. >> and in a phone interview with nbc news' andrea mitchell yesterday he defended the ...